2-하이드록시뷰티르산 (Korean Wikipedia)

Analysis of information sources in references of the Wikipedia article "2-하이드록시뷰티르산" in Korean language version.

refsWebsite

Global rank Korean rank

4^th place

2^nd place

3^rd place

18^th place

27^th place

low place

6,992^nd place

diabetesjournals.org

Ferrannini E, Natali A, Camastra S, Nannipieri M, Mari A, Adam KP, Milburn MV, Kastenmüller G, Adamski J, Tuomi T, Lyssenko V, Groop L, Gall WE (2013). “Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance”. 《Diabetes》 62 (5): 1730–1737. doi:10.2337/db12-0707. PMC 3636608. PMID 23160532.

Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, Nakhle PJ, Ryals JA, Milburn MV, Nannipieri M, Camastra S, Natali A, Ferrannini E, RISC Study Group (2010). “alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population”. 《PLOS ONE》 5 (5): 10883. Bibcode:2010PLoSO...510883G. doi:10.1371/journal.pone.0010883. PMC 2878333. PMID 20526369.
Ferrannini E, Natali A, Camastra S, Nannipieri M, Mari A, Adam KP, Milburn MV, Kastenmüller G, Adamski J, Tuomi T, Lyssenko V, Groop L, Gall WE (2013). “Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance”. 《Diabetes》 62 (5): 1730–1737. doi:10.2337/db12-0707. PMC 3636608. PMID 23160532.

Gall WE, Beebe K, Lawton KA, Adam KP, Mitchell MW, Nakhle PJ, Ryals JA, Milburn MV, Nannipieri M, Camastra S, Natali A, Ferrannini E, RISC Study Group (2010). “alpha-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population”. 《PLOS ONE》 5 (5): 10883. Bibcode:2010PLoSO...510883G. doi:10.1371/journal.pone.0010883. PMC 2878333. PMID 20526369.
Ferrannini E, Natali A, Camastra S, Nannipieri M, Mari A, Adam KP, Milburn MV, Kastenmüller G, Adamski J, Tuomi T, Lyssenko V, Groop L, Gall WE (2013). “Early metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significance”. 《Diabetes》 62 (5): 1730–1737. doi:10.2337/db12-0707. PMC 3636608. PMID 23160532.